Parvathi Mohan

Summary

Affiliation: Children's National Medical Center
Country: USA

Publications

  1. pmc An unusual presentation of perinatally transmitted hepatitis C
    P Mohan
    Department of Pediatric Gastroenterology and Nutrition, Pathology and Laboratory Medicine, Children s National Medical Center, George Washington University School of Medicine, Washington DC 20001, USA
    Arch Dis Child 88:160-1. 2003
  2. pmc Clinical spectrum and histopathologic features of chronic hepatitis C infection in children
    Parvathi Mohan
    Department of Gastroenterology and Nutrition, Children s National Medical Center, Washington, DC 20010, USA
    J Pediatr 150:168-74, 174.e1. 2007
  3. doi request reprint Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: A retrospective study
    Parvathi Mohan
    Children s National Medical Center, The George Washington School of Medicine, Washington, DC
    Hepatology 58:1580-6. 2013
  4. ncbi request reprint The epidemiology of transfusion-associated hepatitis C in a children's hospital
    Naomi L C Luban
    Division of Laboratory Medicine and Pathology, Children s National Medical Center, Washington, DC 20010, USA
    Transfusion 47:615-20. 2007
  5. ncbi request reprint Dental floss ingestion requiring endoscopic retrieval
    N Crain
    Department of Critical Care Medicine, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Emerg Care 16:339-40. 2000
  6. pmc Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
    Zachary D Goodman
    Armed Forces Institute of Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 47:836-43. 2008
  7. pmc Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference
    Meral Gunay-Aygun
    National Human Genome Research Institute, the Molecular Imaging Program, National Cancer Institute, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 1851, USA
    J Pediatr 149:159-64. 2006
  8. ncbi request reprint Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C
    Kathleen B Schwarz
    Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Pediatr Gastroenterol Nutr 43:499-505. 2006
  9. ncbi request reprint Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C
    Adriana A Byrnes
    Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Leukoc Biol 81:825-34. 2007

Detail Information

Publications9

  1. pmc An unusual presentation of perinatally transmitted hepatitis C
    P Mohan
    Department of Pediatric Gastroenterology and Nutrition, Pathology and Laboratory Medicine, Children s National Medical Center, George Washington University School of Medicine, Washington DC 20001, USA
    Arch Dis Child 88:160-1. 2003
    ..The difficulties in establishing the diagnosis and the importance of confirmatory testing for HCV in cryptogenic liver disease are discussed...
  2. pmc Clinical spectrum and histopathologic features of chronic hepatitis C infection in children
    Parvathi Mohan
    Department of Gastroenterology and Nutrition, Children s National Medical Center, Washington, DC 20010, USA
    J Pediatr 150:168-74, 174.e1. 2007
    ..To define the natural history and outcomes of children infected with hepatitis C virus (HCV) at birth or in early childhood...
  3. doi request reprint Evaluating progression of liver disease from repeat liver biopsies in children with chronic hepatitis C: A retrospective study
    Parvathi Mohan
    Children s National Medical Center, The George Washington School of Medicine, Washington, DC
    Hepatology 58:1580-6. 2013
    ..5% (n = 13) of children showed an increase in severity of fibrosis. These findings may have long-term implications for the timing of follow-up biopsies and treatment decisions. (Hepatology 2013;58:1580-1586). ..
  4. ncbi request reprint The epidemiology of transfusion-associated hepatitis C in a children's hospital
    Naomi L C Luban
    Division of Laboratory Medicine and Pathology, Children s National Medical Center, Washington, DC 20010, USA
    Transfusion 47:615-20. 2007
    ..To determine the prevalence of HCV infection and risks associated with acquisition of HCV, a single-institution lookback study was performed...
  5. ncbi request reprint Dental floss ingestion requiring endoscopic retrieval
    N Crain
    Department of Critical Care Medicine, Children s National Medical Center, Washington, DC 20010, USA
    Pediatr Emerg Care 16:339-40. 2000
    ..We report an unusual case of a toddler who ingested dental floss and who subsequently was intubated in a community ED prior to transfer to our pediatric tertiary care center for endoscopic removal of the foreign body...
  6. pmc Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial
    Zachary D Goodman
    Armed Forces Institute of Pathology and Veterans Administration Special Reference Laboratory for Pathology, Washington, DC, USA
    Hepatology 47:836-43. 2008
    ....
  7. pmc Autosomal recessive polycystic kidney disease and congenital hepatic fibrosis: summary statement of a first National Institutes of Health/Office of Rare Diseases conference
    Meral Gunay-Aygun
    National Human Genome Research Institute, the Molecular Imaging Program, National Cancer Institute, The National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892 1851, USA
    J Pediatr 149:159-64. 2006
  8. ncbi request reprint Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C
    Kathleen B Schwarz
    Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
    J Pediatr Gastroenterol Nutr 43:499-505. 2006
    ..In conclusion, our findings provide a basis for larger studies evaluating the efficacy and safety of pegINF-alpha2a as monotherapy as well as in combination with ribavirin in pediatric patients with chronic hepatitis C...
  9. ncbi request reprint Modulation of the IL-12/IFN-gamma axis by IFN-alpha therapy for hepatitis C
    Adriana A Byrnes
    Department of Medicine, Johns Hopkins University, Baltimore, MD, USA
    J Leukoc Biol 81:825-34. 2007
    ..No differences in pretreatment IL-12 productive capacity were seen between patient groups. However, therapy with IFN-alpha led to suppression of inducible IL-12 production throughout the course of therapy in both groups of patients...